2021 Archive

Watch how St. Jude visual storytellers use artistry to support scientific discovery

St. Jude clinicians collaborate with fellow palliative care experts to advocate for bringing palliative care to patients with sickle cell disease.

Learn about how an award-winning scientific collaboration is pushing forward novel cancer therapies.

Meet Suzanne Gronemeyer, PhD, and discover how she built a legacy of education and training at St. Jude.

See how the St. Jude Graduate School of Biomedical Sciences trains students in the Applied Biomedical Data Science MS program.

See how St. Jude scientists turn research into strategies for drugging key cancer pathways.

Two St. Jude efforts independently uncovered the predisposition gene’s role.

See how St. Jude chemists approach drug discovery and development to make the therapies of tomorrow.

Investigate the decades-long cold case that St. Jude researchers finally cracked.

Explore the ingenuity behind therapeutic optimization

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.

For Jasmine Turner, resilience and tenacity were required to enter a field with very few Black women. There weren’t many women or teachers of color in her scientific courses—no one with similar experiences to help guide her or focus her talents. She turned to her mother for encouragement and inspiration.

This study, to our knowledge, is the first to objectively measure hearing and neurocognitive function in a large cohort of long-term survivors of childhood cancer stratified by treatment exposures.